In vivo measurement of myocardial oxidative metabolism and blood flow does not show changes in cancer patients undergoing doxorubicin therapy

Cancer Chemotherapy and Pharmacology

Volumn 45, Issue 5, 2000, Pages 375-380

  Nony, Patrice ^a   Guastalla, Jean Paul ^b   Rebattu, Paul ^b   Landais, Patricia ^c   Lievre, Michel ^a   Bontemps, Laurence ^a   Itti, Roland ^a   Beaune, Jacques ^a   Andre Fouet, Xavier ^a   Janier, Marc ^c  

^a Cardiovascular Hospital   (France)

^b CENTRE LÉON BÉRARD   (France)

^c CERMEP IMAGERIE DU VIVANT   (France)

Author keywords

Anthracyclines; Cardiotoxicity; Doxorubicin; Positron emission tomography

Indexed keywords

CARBON 11; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CINEANGIOGRAPHY; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM TUMOR; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; UTERUS TUMOR;

EID: 0034088958     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051005     Document Type: Article

References (36)

1. 1. Alexander J, Dainiak N, Berger JH, Goldman L, Johnstone D, Reduto L, Duffi T, Schwartz P, Gottschlk A, Zaret BL (1979) Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 300: 278-283
2. 2. Ali MK, Soto PA, Maroongroge D, Bekheit-Saad S, Buzdar AU, Blumenschein GR, Hortobagyi GN, Tashima CK, Wiseman CL, Shullenberger CC (1979) Electrocardiographic changes after Adriamycin chemotherapy. Cancer 43: 465-471
3. 3. Armbrecht JJ, Buxton DB, Schelbert HR (1990) Validation of (1-11 °C) acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 81: 1594-1605
4. 4. Beanlands RS, Shaikh NA, Wen WH, Dawood F, Ugnat AM, McLaughlin PR, Carere R, Liu PP (1994) Alterations in fatty acid metabolism in Adriamycin cardiomyopathy. J Mol Cell Cardiol 26: 109-119
5. 5. Bristow MR, Billingham ME, Mason JW, Daniels JR (1978) Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 62: 873-879
6. 6. Brown KA, Blow AJ, Weiss RM, Stewart JA (1989) Acute effects of doxorubicin on human left ventricular systolic and diastolic function. Am Heart J 118: 979-982
7. 7. Choi BW, Berger HJ, Schwartz PE, Alexander J, Wacker FJT, Gottschalk A, Zaret BL (1983) Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance. Am Heart J 106: 638-643
8. 8. Cittadin A, Fazio S, D'Ascia C, Basso A, Bazzicalpupo L, Picardi G, Sacca L (1991) Subclinical cardiotoxicity by doxorubicin: a pulsed Doppler echocardiographic study. Eur Heart J 12: 1000-1005
9. 9. Combs AB, Acosta D (1990) Toxic mechanisms of the heart: a review. Toxicol Pathol 18: 583-596
10. 10. Coppens A, Sibomana M, Bol A, Michel C (1993) MEDIMAN: an object oriented programming approach for medical image analysis. IEEE Trans Nucl Sci 40: 950-955
11. 11. Czernin J, Müller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Schelbert HR (1993) Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88: 62-69
12. 12. Decorti G, Candussio L, Klugmann FB, Strohmayer A, Mucci MP, Mosco A, Baldini L (1997) Adriamycin-induced histamine release from heart tissue in vitro. Cancer Chemother Pharmacol 40: 363-366
13. 13. Ditchey RV, LeWinter MM, Higgins CB (1984) Acute effects of doxorubicin (Adriamycin) on left ventricular function in dogs. Int J Cardiol 6: 341-353
14. 14. Druck MN, Gulenchyn KY, Evans WK, Gotlieb A, Srigley JR, Ben-Zion Bar-Shlomo, Feiglin DH, McEwan P, Silver MD, Millband L, Winter K, Hilton JD, Jablonsky G, Morch JE, McLaughlin P (1984) Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity. Cancer 53: 1667-1674
15. 15. Faber M, Coudray C, Hida H, Mousseau M, Favier A (1995) Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including Adriamycin. A preliminary study. Biol Trace Elem Res 47: 117-123
16. 16. Gottdiener JS, Mathisen DJ, Borer JS, Bonow RO, Myers CE, Barr LH, Schartz DE, Bacharach SL, Green MV, Rosenberg SA (1981) Doxorubicin cardiotoxicity: assessment of the left ventricular dysfunction by radionuclide cineangiography. Ann Intern Med 94: 430-435
17. 2 mismatch during inotropic stress in CAD patients with normal contractile function. Am J Physiol 271: H59-H67
18. 18. Jensen RA (1986) Doxorubicin cardiotoxicity: contractile changes after long term treatment in the rat. J Pharmacol Exp Ther 236: 197-203
19. 19. Krivokapich J, Huang SC, Schelbert HR (1993) Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol 71: 1351-1356
20. 20. Lee BH, Goodenday LS, Muswick GJ, Yasnoff WA, Leighton RF, Skeel RT (1987) Alterations in left ventricular diastolic function with doxorubicin therapy. J Am Coll Cardiol 9: 184-188
21. 21. Lenaz L, Page JA (1976) Cardiotoxicity of Adriamycin and related anthracyclines. Cancer Treat Rev 3: 111-120
22. 22. Marcillat O, Zhang Y, Davies KJA (1989) Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin. Biochem J 259: 181-189
23. 23. Mazoyer BM, Trebossen R, Schoukroun C, Verrey B, Syrota A, Vacher J, Lemasson P, Monnet O, Bouvier A, Lecomte JL (1990) Physical characteristics of TTV03, a new high spatial resolution time-of-flight positron tomograph. IEEE Trans Nucl Sci 37: 778-782
24. 24. McKillop JH, Bristow MR, Goris ML, Billingham ME, Bockemuehl K (1983) Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J 106: 1048-1056
25. 25. Myers C, Bonow R, Palmeri S, Jenkins J, Corden B, Locker G, Doroshow J, Epstein S (1983) A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol 10: 53-55
26. 26. Olson HM, Young DM, Prieur DJ, LeRoy AF, Reagan RL (1974) Electrolyte and morphological alterations of myocardium in Adriamycin-treated rabbits. Am J Pathol 77: 439-454
27. 27. Olson RD, Mushlin PS (1990) Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 4: 3076-3086
28. 28. Pike VW, Eakins MN, Allan RM, Selwyn AP (1981) Preparation of carbon-11 labeled acetate and palmitic acid for the study of myocardial metabolism by emission-computerised axial tomography. J Radioanal Chem 64: 291-297
29. 29. Piver MS, Marchetti DL, Parthasarathy KL, Bakshi S, Reese P (1985) Doxorubicin hydrochloride (Adriamycin) cardiotoxicity evaluated by sequential radionuclide angiography. Cancer 56: 76-80
30. 30. Rajagopalan S, Politi PM, Sinha BK, Myers CE (1988) Adriamycin-induced free radical formation in the perfused rat heart: implications of cardiotoxicity. Cancer Res 48: 4766-4769
31. 31. Robinson BA, Coll BM, Turner JG (1983) Adriamycin cardiotoxicity monitoring by radionuclide scan. Br J Cancer 48: 315-317
32. 32. Singer JW, Narahara KA, Ritchier JL, Hamilon GW, Kennedy JW (1978) Time-and dose-dependent changes in ejection fraction determined by radionuclide angiography after anthracycline therapy. Cancer Treat Rep 62: 945-948
33. 33. Unverferth DV, Magorien RD, Unverferth BP, Talley RL, Balzerzak SP, Baba N (1981) Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration. Cancer Treat Rep 65: 1093-1097
34. 34. Unverferth DV, Leier CV, Valcerzak SP, Hamlin RL (1985) Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs. Am J Cardiol 56: 157-161
35. 35. Wortman JE, Lucas VS Jr, Schuster E, Thiele D, Logue GL (1979) Sudden death during doxorubicin administration. Cancer 44: 1588-1591
36. 36. Zanon PL, Pozzoli EF, Bellini O (1976) Myocardial injury induced by a single dose of Adriamycin: an electron microscopic study. Tumori 62: 517-528